TransCode Therapeutics (RNAZ)
1.66
0.00 (0.00%)
Upcoming Events
Latest Headlines
TransCode Therapeutics to present TTX-MC138 trial data at ESMO 2026
October 19, 2026 8:04 AM - StreetInsider
TransCode Therapeutics to Present Phase 1a Clinical Trial Data for TTX-MC138 at ESMO Congress 2026
October 19, 2026 8:04 AM - PR NewsWire
Natera and TransCode team up on colorectal cancer MRD trial
October 13, 2026 7:30 AM - StreetInsider
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
October 13, 2026 7:30 AM - BizWire
Form 8-K Transcode Therapeutics, For: Oct 01
October 1, 2026 4:05 PM - SEC Filing
Form 8-K Transcode Therapeutics, For: Sep 28
September 28, 2026 8:16 AM - SEC Filing
TransCode reports Phase 1a trial data for TTX-MC138 in solid tumors
September 28, 2026 8:04 AM - StreetInsider
TransCode Reports Continued Disease Stabilization and Extended Treatment Duration with TTX-MC138 in Ongoing Phase 1a Clinical Trial Follow-Up
September 28, 2026 8:04 AM - PR NewsWire
TransCode Therapeutics receives patent approvals in Australia and Japan
September 22, 2026 8:04 AM - StreetInsider
TransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology
September 22, 2026 8:04 AM - PR NewsWire
Form 3 Transcode Therapeutics, For: Sep 10 Filed by: Tattory John A
September 21, 2026 5:42 PM - SEC Filing
Join Today's Live Investor Webinar with TransCode Therapeutics
September 16, 2026 9:01 AM - StreetInsider
Form 4 Transcode Therapeutics, For: Sep 09 Filed by: Fitzgerald Thomas A
September 11, 2026 5:10 PM - SEC Filing
Form 8-K Transcode Therapeutics, For: Sep 09
September 11, 2026 5:01 PM - SEC Filing
TransCode Therapeutics CFO Tom Fitzgerald retires, replaced interim
September 10, 2026 4:13 PM - StreetInsider
TransCode Therapeutics Announces Leadership Transition
September 10, 2026 4:10 PM - PR NewsWire
Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Cancer
September 3, 2026 9:00 AM - StreetInsider
Form 10-Q Transcode Therapeutics, For: Jun 30
August 14, 2026 5:06 PM - SEC Filing
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
August 7, 2026 9:01 AM - StreetInsider
Form 4 Transcode Therapeutics, For: Aug 03 Filed by: CK Life Sciences Intl (Holdings) Inc
August 5, 2026 4:06 PM - SEC Filing
Form 3 Transcode Therapeutics, For: Jul 27 Filed by: CK Life Sciences Intl (Holdings) Inc
August 5, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13D/A Transcode Therapeutics, Filed by: CK Life Sciences Intl (Holdings) Inc
August 3, 2026 4:39 PM - SEC Filing
Form 8-K Transcode Therapeutics, For: Aug 03
August 3, 2026 4:16 PM - SEC Filing
Form SCHEDULE 13G Transcode Therapeutics, Filed by: Unleash Immuno Oncolytics, Inc.
July 28, 2026 7:52 PM - SEC Filing
Form SCHEDULE 13G Transcode Therapeutics, Filed by: Braci Elena Rosa
July 28, 2026 7:51 PM - SEC Filing
Form SCHEDULE 13G Transcode Therapeutics, Filed by: Katzman Daniel Eduardo
July 28, 2026 7:49 PM - SEC Filing
Form SCHEDULE 13D/A Transcode Therapeutics, Filed by: CK Life Sciences Intl (Holdings) Inc
July 27, 2026 4:15 PM - SEC Filing
Full Article List
